The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2019 / Feb / In Conversation with Dr. Martin Klatt of BASF
Discovery & Development Formulation Sponsored

In Conversation with Dr. Martin Klatt of BASF

02/20/2019 0 min read

Sponsored By

Share

The Medicine Maker's James Strachan met with business leaders and specialists to discuss the latest innovations and trends in pharmaceutical manufacturing.
Here, James speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Meeting the Demands of Injectable Drug Delivery
Drug Delivery
Meeting the Demands of Injectable Drug Delivery

October 22, 2026

1 min read

Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations

The Confidentiality Barrier to AI-Enabled Drug Development
Small Molecules Small Molecules Formulation
The Confidentiality Barrier to AI-Enabled Drug Development

July 27, 2026

3 min read

AI can help formulation teams better predict performance and allocate resources, but proprietary data protections remain a critical bottleneck

Why Drug Development Still Lacks Integration
Small Molecules Small Molecules Business & Trends
Why Drug Development Still Lacks Integration

July 21, 2026

4 min read

John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines

In Vivo CAR T: A New Route to Treating Autoimmune Disease
Cell & Gene Drug Delivery Development & Clinical
In Vivo CAR T: A New Route to Treating Autoimmune Disease

July 13, 2026

6 min read

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: